Anti-VEGF (Bevacizumab), Humanized Antibody

Anti-VEGF (Bevacizumab), Humanized Antibodyis available at Gentaur for Next week Delivery.

Description: Bevacizumab is a recombinant humanized monoclonal IgG1 antibody. Bevacizumab, targets the cell surface protein called vascular endothelial growth factor (VEGF) results in suppression of tumor growth. VEGF plays an essential role in developmental angiogenesis and is also important for reproductive and bone angiogenesis. Avastin is used to treat various cancers like metastatic colorectal cancer, non-squamous non–small cell lung cancer, metastatic breast cancer, glioblastoma and metastatic renal cell carcinoma.

Immunogen Sequence:Recombinant human VEGF

Target Alternative Name:ABP 215, ABP-215, R-435, rhuMAb-VEGF

Species Reactivities:Human

Tag Line:Monoclonal human IgG1 antibody against human VEGF

Formulation:100 ug (2 mg/ml) of antibody in Phosphate buffered saline, pH 7.4.

Purification: human IgG1 was expressed in a human cell line. IgG was purified from CHO cell culture supernatant by protein A chromatography.

Application:Neutralization, ELISA

Positive Control:/

Application And Usages:Neutralization: 0.1-20 μg/ml, ELISA: 2 μg/ml

Handling:The antibody solution should be gently mixed before use